These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 11793424

  • 1. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.
    Kilbourn MR, Sherman PS, Kuszpit K.
    Synapse; 2002 Mar 01; 43(3):188-94. PubMed ID: 11793424
    [Abstract] [Full Text] [Related]

  • 2. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR, Kuszpit K, Sherman P.
    Synapse; 2000 Mar 15; 35(4):250-5. PubMed ID: 10657034
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain.
    Kilbourn MR, Kemmerer ES, Desmond TJ, Sherman PS, Frey KA.
    Exp Neurol; 2004 Aug 15; 188(2):387-90. PubMed ID: 15246838
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term reproducibility of in vivo measures of specific binding of radioligands in rat brain.
    Kilbourn MR.
    Nucl Med Biol; 2004 Jul 15; 31(5):591-5. PubMed ID: 15219277
    [Abstract] [Full Text] [Related]

  • 6. Analysis of four dopaminergic tracers kinetics using two different tissue input function methods.
    Sossi V, Holden JE, Chan G, Krzywinski M, Stoessl AJ, Ruth TJ.
    J Cereb Blood Flow Metab; 2000 Apr 15; 20(4):653-60. PubMed ID: 10779009
    [Abstract] [Full Text] [Related]

  • 7. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.
    Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE.
    J Cereb Blood Flow Metab; 1997 Sep 15; 17(9):919-31. PubMed ID: 9307605
    [Abstract] [Full Text] [Related]

  • 8. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.
    Brown JM, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2001 Sep 15; 298(3):1150-3. PubMed ID: 11504813
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.
    Koeppe RA, Frey KA, Vander Borght TM, Karlamangla A, Jewett DM, Lee LC, Kilbourn MR, Kuhl DE.
    J Cereb Blood Flow Metab; 1996 Nov 15; 16(6):1288-99. PubMed ID: 8898703
    [Abstract] [Full Text] [Related]

  • 11. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M, Desmond TJ, Albin RL, Frey KA.
    Synapse; 2001 Sep 15; 41(4):329-36. PubMed ID: 11494403
    [Abstract] [Full Text] [Related]

  • 12. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters.
    Kilbourn MR, Frey KA, Vander Borght T, Sherman PS.
    Nucl Med Biol; 1996 May 15; 23(4):467-71. PubMed ID: 8832701
    [Abstract] [Full Text] [Related]

  • 13. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
    Brown JM, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2001 Mar 15; 296(3):762-7. PubMed ID: 11181904
    [Abstract] [Full Text] [Related]

  • 14. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M.
    J Med Chem; 2005 Apr 07; 48(7):2559-70. PubMed ID: 15801845
    [Abstract] [Full Text] [Related]

  • 15. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
    Staal RG, Hogan KA, Liang CL, German DC, Sonsalla PK.
    J Pharmacol Exp Ther; 2000 May 07; 293(2):329-35. PubMed ID: 10772999
    [Abstract] [Full Text] [Related]

  • 16. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT, Bondi CD, Newman AH, Kulkarni SS, Kozikowski AP, Pan S, Surratt CK.
    J Pharmacol Exp Ther; 2005 Aug 07; 314(2):575-83. PubMed ID: 15879005
    [Abstract] [Full Text] [Related]

  • 17. In vivo binding of (+)-alpha-[3H]dihydrotetrabenazine to the vesicular monoamine transporter of rat brain: bolus vs. equilibrium studies.
    Kilbourn M, Sherman P.
    Eur J Pharmacol; 1997 Jul 23; 331(2-3):161-8. PubMed ID: 9274975
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo measurement of the vesicular monoamine transporter in schizophrenia.
    Taylor SF, Koeppe RA, Tandon R, Zubieta JK, Frey KA.
    Neuropsychopharmacology; 2000 Dec 23; 23(6):667-75. PubMed ID: 11063922
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.